REGULATION OF C1 INHIBITOR SYNTHESIS
C1 抑制剂合成的调控
基本信息
- 批准号:6637255
- 负责人:
- 金额:$ 30.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-02-01 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from investigator's abstract): Hereditary angioedema
develops in individuals heterozygous for C1 inhibitor (C1INH) deficiency. The
product of a single allele is insufficient to control activation of the
proteolytic systems normally regulated by C1INH. A logical approach to therapy
is to enhance inhibitor synthesis from this single gene. This proposal will
examine three aspects of C1INH synthesis regulation that have not been studied
extensively in any gene and that remain poorly understood. Specific Aim 1 will
examine the role of the polypurine-polypyrimidine (Pu-Py) segment of the C1INH
promoter. We will test the hypothesis that enhanced transcription mediated by
this region results from interaction of transcription factors with specific
sequences within the Pu-Py segment rather than via H-DNA (triple helix hinged)
formation. Preliminary electrophoretic mobility shift assays and supershift
experiments have demonstrated interaction of HNF-1alpha (hepatocyte nuclear
factor) with one site in addition to several other, as yet unidentified,
nuclear proteins that bind to sites within the region containing the Pu-Py
sequence. Further studies will identify and characterize these proteins and
their function. Other studies suggest cooperativity between the Pu-Py region
and the HNF-1alpha site. We will test the hypothesis that this cooperativity
results from interaction between transcription factors that bind to these
regions by co-immunoprecipitation and by direct isolation. DNAse
hypersensitivity experiments will be performed to provide support for the
hypothesis that H-DNA formation takes place in vivo, as will experiments to
analyze induction of transcription using mutated promoter constructs that are
incapable of H-DNA formation. Lastly, nucleosomal reconstitution experiments
will test the hypothesis that triplex formation creates a nucleosomal barrier
during replication.
Specific Aim 2 will examine the role of phosphatases in down-regulating
interferon (IFN)-gamma-mediated induction of C1INH in hepatocytes in comparison
with the role of proteosome degradation or binding of STAT1 by specific
inhibitory proteins. Preliminary data suggest that phosphatases play a major
role in this down-regulation. This hypothesis is unexamined in hepatocytes,
which are the primary source of most plasma proteins, many of which are
IFN-responsive. Specific Aim 3 will test the hypothesis that estrogens suppress
C1INH transcription. Furthermore, we hypothesize that the therapeutic effect of
androgens is a result of down-regulation of estrogen receptor expression, which
reverses the estrogenic effect. The studies proposed here will contribute both
to knowledge of the regulation of C1INH itself and to the role of hormones,
nuclear phosphatases and Pu-Py sequences on gene regulation in general.
描述(摘自研究人员摘要):遗传性血管性水肿
在C1INH缺乏的杂合子个体中发展。这个
单个等位基因的产物不足以控制基因的激活
蛋白分解系统通常由C1INH调节。治疗的合乎逻辑的方法
是为了加强从这个单一基因合成抑制物。这项提议将
考察尚未研究过的C1INH合成调控的三个方面
在任何基因中都广泛存在,但人们对此仍知之甚少。具体目标1将
研究C1INH的多嘌呤-多嘧啶(Pu-Py)片段的作用
推动者。我们将检验这样一种假设,即通过
这个区域是转录因子与特定基因相互作用的结果。
Pu-Py片段内的序列而不是通过H-DNA(三螺旋铰链)
队形。初步的电泳迁移率变化分析和超迁移
实验证明了HNF-1α(肝细胞核)的相互作用
因素),除了一个地点外,还有其他几个地点,
与含有Pu-Py的区域内的位置结合的核蛋白
序列。进一步的研究将鉴定和鉴定这些蛋白质和
它们的功能。其他研究表明,Pu-Py区域之间存在协同作用
和HNF-1α位点。我们将检验这样一个假设,即这种合作性
结合这些转录因子的转录因子之间相互作用的结果
免疫共沉淀法和直接分离法。DNA酶
将进行过敏性实验,为
假设H-DNA在体内形成,实验也将如此
使用突变的启动子结构分析转录的诱导
不能形成H-DNA。最后,核小体重组实验。
将检验三链形成会产生核小体屏障的假说
在复制期间。
特定目标2将研究磷酸酶在下调中的作用
干扰素-γ诱导肝细胞C1INH的比较
与蛋白酶体降解或通过特异性结合STAT1的作用
抑制蛋白。初步数据表明,磷酸酶起着主要作用
在这一下调监管中扮演的角色。这一假说在肝细胞中未经检验,
它们是大多数血浆蛋白的主要来源,其中许多是
干扰素反应。《特指目标3》将检验雌激素抑制
C1INH转录。此外,我们还假设阿司匹林的疗效
雄激素是雌激素受体表达下调的结果,
逆转雌激素的作用。这里提出的研究将对
对C1INH本身的调节和激素的作用的了解,
核磷酸酶和Pu-Py序列对基因调控的一般作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALVIN E DAVIS其他文献
ALVIN E DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALVIN E DAVIS', 18)}}的其他基金
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
- 批准号:
7173831 - 财政年份:2005
- 资助金额:
$ 30.47万 - 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
- 批准号:
7392241 - 财政年份:2005
- 资助金额:
$ 30.47万 - 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
- 批准号:
6917375 - 财政年份:2005
- 资助金额:
$ 30.47万 - 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
- 批准号:
7544502 - 财政年份:2005
- 资助金额:
$ 30.47万 - 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
- 批准号:
7010675 - 财政年份:2005
- 资助金额:
$ 30.47万 - 项目类别:
相似海外基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 30.47万 - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 30.47万 - 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
- 批准号:
RGPIN-2019-04999 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Discovery Grants Program - Individual
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
- 批准号:
10418461 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10570208 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10355174 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
- 批准号:
2744296 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10525097 - 财政年份:2022
- 资助金额:
$ 30.47万 - 项目类别:














{{item.name}}会员




